499 related articles for article (PubMed ID: 30131805)
1. Dectin-3 Recognizes Glucuronoxylomannan of
Huang HR; Li F; Han H; Xu X; Li N; Wang S; Xu JF; Jia XM
Front Immunol; 2018; 9():1781. PubMed ID: 30131805
[No Abstract] [Full Text] [Related]
2. Immunomodulatory effects of serotype B glucuronoxylomannan from Cryptococcus gattii correlate with polysaccharide diameter.
Fonseca FL; Nohara LL; Cordero RJ; Frases S; Casadevall A; Almeida IC; Nimrichter L; Rodrigues ML
Infect Immun; 2010 Sep; 78(9):3861-70. PubMed ID: 20547742
[TBL] [Abstract][Full Text] [Related]
3. A Glucuronoxylomannan Epitope Exhibits Serotype-Specific Accessibility and Redistributes towards the Capsule Surface during Titanization of the Fungal Pathogen Cryptococcus neoformans.
Probert M; Zhou X; Goodall M; Johnston SA; Bielska E; Ballou ER; May RC
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670549
[TBL] [Abstract][Full Text] [Related]
4. Role of Dectin-2 in the Phagocytosis of Cryptococcus neoformans by Dendritic Cells.
Kitai Y; Sato K; Tanno D; Yuan X; Umeki A; Kasamatsu J; Kanno E; Tanno H; Hara H; Yamasaki S; Saijo S; Iwakura Y; Ishii K; Kawakami K
Infect Immun; 2021 Sep; 89(10):e0033021. PubMed ID: 34251289
[TBL] [Abstract][Full Text] [Related]
5. CARD9 Is Required for Classical Macrophage Activation and the Induction of Protective Immunity against Pulmonary Cryptococcosis.
Campuzano A; Castro-Lopez N; Martinez AJ; Olszewski MA; Ganguly A; Leopold Wager C; Hung CY; Wormley FL
mBio; 2020 Jan; 11(1):. PubMed ID: 31911495
[TBL] [Abstract][Full Text] [Related]
6. Evasion of Innate Immune Responses by the Highly Virulent Cryptococcus gattii by Altering Capsule Glucuronoxylomannan Structure.
Urai M; Kaneko Y; Ueno K; Okubo Y; Aizawa T; Fukazawa H; Sugita T; Ohno H; Shibuya K; Kinjo Y; Miyazaki Y
Front Cell Infect Microbiol; 2015; 5():101. PubMed ID: 26779451
[TBL] [Abstract][Full Text] [Related]
7. C-type lectin receptor dectin-3 mediates trehalose 6,6'-dimycolate (TDM)-induced Mincle expression through CARD9/Bcl10/MALT1-dependent nuclear factor (NF)-κB activation.
Zhao XQ; Zhu LL; Chang Q; Jiang C; You Y; Luo T; Jia XM; Lin X
J Biol Chem; 2014 Oct; 289(43):30052-62. PubMed ID: 25202022
[TBL] [Abstract][Full Text] [Related]
8. Cryptococcus gattii alters immunostimulatory potential in response to the environment.
Ueno K; Otani Y; Yanagihara N; Nakamura T; Shimizu K; Yamagoe S; Miyazaki Y
PLoS One; 2019; 14(8):e0220989. PubMed ID: 31398236
[TBL] [Abstract][Full Text] [Related]
9. Contribution of Laccase Expression to Immune Response against Cryptococcus gattii Infection.
Hansakon A; Ngamskulrungroj P; Angkasekwinai P
Infect Immun; 2020 Feb; 88(3):. PubMed ID: 31871099
[TBL] [Abstract][Full Text] [Related]
10. Dectin-2 deficiency promotes Th2 response and mucin production in the lungs after pulmonary infection with Cryptococcus neoformans.
Nakamura Y; Sato K; Yamamoto H; Matsumura K; Matsumoto I; Nomura T; Miyasaka T; Ishii K; Kanno E; Tachi M; Yamasaki S; Saijo S; Iwakura Y; Kawakami K
Infect Immun; 2015 Feb; 83(2):671-81. PubMed ID: 25422263
[TBL] [Abstract][Full Text] [Related]
11. C-Type Lectin Receptor CD23 Is Required for Host Defense against
Guo Y; Chang Q; Cheng L; Xiong S; Jia X; Lin X; Zhao X
J Immunol; 2018 Oct; 201(8):2427-2440. PubMed ID: 30185519
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary Iron Limitation Induced by Exogenous Type I IFN Protects Mice from Cryptococcus gattii Independently of T Cells.
Davis MJ; Moyer S; Hoke ES; Sionov E; Mayer-Barber KD; Barber DL; Cai H; Jenkins L; Walter PJ; Chang YC; Kwon-Chung KJ
mBio; 2019 Jun; 10(3):. PubMed ID: 31213551
[No Abstract] [Full Text] [Related]
13. Pyrifenox, an ergosterol inhibitor, differentially affects Cryptococcus neoformans and Cryptococcus gattii.
Silva VKA; May RC; Rodrigues ML
Med Mycol; 2020 Oct; 58(7):928-937. PubMed ID: 31915833
[TBL] [Abstract][Full Text] [Related]
14. Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection.
Campuzano A; Castro-Lopez N; Wozniak KL; Leopold Wager CM; Wormley FL
PLoS One; 2017; 12(1):e0169347. PubMed ID: 28107361
[TBL] [Abstract][Full Text] [Related]
15. Spleen deposition of Cryptococcus neoformans capsular glucuronoxylomannan in rodents occurs in red pulp macrophages and not marginal zone macrophages expressing the C-type lectin SIGN-R1.
De Jesus M; Park CG; Su Y; Goldman DL; Steinman RM; Casadevall A
Med Mycol; 2008 Mar; 46(2):153-62. PubMed ID: 18324494
[TBL] [Abstract][Full Text] [Related]
16. The primary target organ of Cryptococcus gattii is different from that of Cryptococcus neoformans in a murine model.
Ngamskulrungroj P; Chang Y; Sionov E; Kwon-Chung KJ
mBio; 2012; 3(3):. PubMed ID: 22570277
[TBL] [Abstract][Full Text] [Related]
17. Clinical and microbiological characteristics of cryptococcosis in Singapore: predominance of Cryptococcus neoformans compared with Cryptococcus gattii.
Chan M; Lye D; Win MK; Chow A; Barkham T
Int J Infect Dis; 2014 Sep; 26():110-5. PubMed ID: 25018090
[TBL] [Abstract][Full Text] [Related]
18. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
19. Cryptococcus gattii polysaccharide capsule: An insight on fungal-host interactions and vaccine studies.
Freitas GJC; Santos DA
Eur J Immunol; 2021 Sep; 51(9):2206-2209. PubMed ID: 34396521
[TBL] [Abstract][Full Text] [Related]
20. Interferon-γ promotes phagocytosis of Cryptococcus neoformans but not Cryptococcus gattii by murine macrophages.
Ikeda-Dantsuji Y; Ohno H; Tanabe K; Umeyama T; Ueno K; Nagi M; Yamagoe S; Kinjo Y; Miyazaki Y
J Infect Chemother; 2015 Dec; 21(12):831-6. PubMed ID: 26477011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
